Professor James Moore of Imperial College London is developing an implant called Faciliflow to treat breast cancer-associated lymphedema. This condition occurs as a result of the removal of lymph nodes during breast cancer surgery, and can cause chronic, painful swelling of the arm for the rest of the patient's life. One of the key advantages of this approach is that it can be implemented at the time of the original surgery, which means that patients can potentially avoid the debilitating effects of lymphedema altogether. This innovative implant has the potential to greatly improve the quality of life for breast cancer survivors.

Dr. Gregory Martin is a medical device executive and entrepreneur with over 25 years of experience in industry, academia, and consulting. Greg imparts his wisdom by sharing five important lessons in medical device conceptualization, development, and commercialization.

Dr. Alex Nemiroski is an industry expert in DNA sequencing, as well as the founder and CEO of BioNexus Consulting, whose mission is to enable life sciences companies to bring disruptive tools to market at lightning speed. We discuss the past, present, and future of DNA sequencing, including both its medical and non-medical applications.

Dr. Cameron Taylor is a research scientist at the K. Lisa Yang Center for Bionics at MIT, co-directed by Professor Hugh Herr. Cameron's work led to the development of magnetomicrometry, a new technique enabling precise, real-time tracking of muscle contraction during movement. Cameron's work has exciting prospects for the control of wearable robotics including prostheses and exoskeletons, and is not too far away from being tried out in humans. Listen to learn more!

Dr. John Samuelsson is a medical data scientist and graduate of the MIT Health Sciences and Technology program. For his PhD, he explored the use of encephalography to sense activity in the cerebellum, a structure at the back of the brain that has an extremely high density of neurons and is critical for movement, coordination, and attention. His work could lead to new monitoring and diagnostic approaches aimed at cerebellar pathologies.

Dr. James Choi is an associate professor at Imperial College London and is one of the world's leading experts on focused ultrasound (FUS), a technology with huge therapeutic potential for neurological diseases. Check out this episode if you want to learn what all the FUS is about.

Jose Amich and Raahil Sha are the co-founders of Zeta Surgical, a startup focused on navigation for neurosurgical procedures. As CEO and CTO, this dynamic duo is taking their groundbreaking work to the FDA and to a clinical trial early next year. Our conversation explores their unique technology and their vision for what it can bring to neurosurgery, both inside and outside the operating room.

Dr. Jesse Kirkpatrick completed his PhD in the Harvard-MIT Division of Health Sciences and Technology. In this podcast, we discuss his thesis work in early detection of lung adenocarcinoma, and contextualize it within the broader field of synthetic biomarker diagnostics.